Search

Author/Creator McPhail, Neil

1. Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol. Issue 10323 (29th January 2022)

Authors:
Attard, Gerhardt; Murphy, Laura; Clarke, Noel W; Cross, William; Jones, Robert J; Parker, Christopher C; Gillessen, Silke; Cook, Adrian; Brawley, Chris; Amos, Claire L; Atako, Nafisah; Pugh, Cheryl; Buckner, Michelle; Chowdhury, Simon; Malik, Zafar; Russell, J Martin; Gilson, Clare; Rush, Hannah;...
Journal:
Lancet
Issue:
Volume 399:Issue 10323(2022)
Page Start:
447
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Quality of Life in Men With Prostate Cancer Randomly Allocated to Receive Docetaxel or Abiraterone in the STAMPEDE Trial. Issue 8 (10th March 2022)

Authors:
Rush, Hannah L.; Murphy, Laura; Morgans, Alicia K.; Clarke, Noel W.; Cook, Adrian D.; Attard, Gerhardt; Macnair, Archie; Dearnaley, David P.; Parker, Christopher C.; Russell, J. Martin; Gillessen, Silke; Matheson, David; Millman, Robin; Brawley, Christopher D.; Pugh, Cheryl; Tanguay, Jacob S.; Jo...
Journal:
Journal of clinical oncology
Issue:
Volume 40:Issue 8(2022)
Page Start:
825
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search